PTC Therapeutics (NasdaqGS:PTCT) 2025 Conference Transcript

PTC Therapeutics (NasdaqGS:PTCT) 2025 Conference November 18, 2025 03:00 AM ET Company ParticipantsMatt Klein - CEOPierre Gravier - CFOConference Call ParticipantsClara Dahn - Biotech AnalystClara DahnGood morning, everyone. Thanks for joining Jefferies' Healthcare Conference in London. My name is Clara Dahn, one of the biotech analysts here. Here sitting next to me, we have the team of PTC Therapeutics, Matt Klein, CEO of PTC, and Pierre Gravier, Chief Financial Officer of PTC. Welcome.Matt KleinThank you, ...